1. Home
  2. CYCC vs BRFH Comparison

CYCC vs BRFH Comparison

Compare CYCC & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • BRFH
  • Stock Information
  • Founded
  • CYCC 1992
  • BRFH 2005
  • Country
  • CYCC Malaysia
  • BRFH United States
  • Employees
  • CYCC N/A
  • BRFH N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • BRFH Packaged Foods
  • Sector
  • CYCC Health Care
  • BRFH Consumer Staples
  • Exchange
  • CYCC Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • CYCC 47.6M
  • BRFH 43.8M
  • IPO Year
  • CYCC N/A
  • BRFH N/A
  • Fundamental
  • Price
  • CYCC $0.35
  • BRFH $2.50
  • Analyst Decision
  • CYCC Strong Buy
  • BRFH Strong Buy
  • Analyst Count
  • CYCC 1
  • BRFH 1
  • Target Price
  • CYCC $11.00
  • BRFH $4.50
  • AVG Volume (30 Days)
  • CYCC 7.1M
  • BRFH 6.9K
  • Earning Date
  • CYCC 05-13-2025
  • BRFH 05-01-2025
  • Dividend Yield
  • CYCC 43.71%
  • BRFH N/A
  • EPS Growth
  • CYCC N/A
  • BRFH N/A
  • EPS
  • CYCC N/A
  • BRFH N/A
  • Revenue
  • CYCC $43,000.00
  • BRFH $10,818,000.00
  • Revenue This Year
  • CYCC $137.21
  • BRFH $41.20
  • Revenue Next Year
  • CYCC N/A
  • BRFH $42.03
  • P/E Ratio
  • CYCC N/A
  • BRFH N/A
  • Revenue Growth
  • CYCC N/A
  • BRFH 22.03
  • 52 Week Low
  • CYCC $0.17
  • BRFH $1.44
  • 52 Week High
  • CYCC $4.00
  • BRFH $4.61
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 65.97
  • BRFH 43.88
  • Support Level
  • CYCC $0.23
  • BRFH $2.64
  • Resistance Level
  • CYCC $0.30
  • BRFH $2.97
  • Average True Range (ATR)
  • CYCC 0.06
  • BRFH 0.17
  • MACD
  • CYCC 0.01
  • BRFH 0.05
  • Stochastic Oscillator
  • CYCC 68.57
  • BRFH 31.65

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: